NCT03200847 2024-10-01Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced MelanomaUniversity of Colorado, DenverPhase 1/2 Completed26 enrolled 13 charts
NCT02403778 2023-09-21Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced MelanomaUniversity of Colorado, DenverPhase 2 Completed10 enrolled 12 charts